Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 87 52894 860132 331137 952--
Entreprise Value (EV)1 102 011109 142144 340151 130149 231146 526
P/E ratio 29,2x44,0x97,9x47,8x32,5x24,1x
Yield 4,05%3,74%2,78%2,68%2,71%2,77%
Capitalization / Revenue 3,90x4,29x5,43x5,17x4,56x4,05x
EV / Revenue 4,54x4,94x5,92x5,66x4,93x4,30x
EV / EBITDA 15,2x15,3x21,6x19,2x14,9x11,9x
Price to Book 5,85x7,61x10,00x10,5x9,65x8,09x
Nbr of stocks (in thousands) 1 265 9821 266 8121 311 9131 312 296--
Reference price (USD) 69,174,9101105105105
Last update 02/02/201802/14/201902/14/202010/23/202010/23/202010/23/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 22 46522 09024 38426 70330 26434 088
EBITDA1 6 7137 1406 6867 85710 00112 289
Operating profit (EBIT)1 6 8555 6726 4367 4479 18511 155
Operating Margin 30,5%25,7%26,4%27,9%30,3%32,7%
Pre-Tax Profit (EBT)1 2 2271 9931 5483 9526 1958 772
Net income1 3 0012 1551 3353 0744 5306 132
Net margin 13,4%9,76%5,47%11,5%15,0%18,0%
EPS2 2,371,701,032,203,234,36
Dividend per Share2 2,802,802,802,822,852,91
Last update 02/02/201802/14/201902/14/202010/23/202010/23/202010/23/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 14 48314 28212 00913 17811 2788 573
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,16x2,00x1,80x1,68x1,13x0,70x
Free Cash Flow1 2 2521 5751 9903 5135 9987 863
ROE (Net Profit / Equities) 36,4%32,0%35,6%41,4%51,7%58,1%
Shareholders' equity1 8 2506 7423 7527 4168 76810 548
ROA (Net Profit / Asset) 4,77%7,07%2,19%7,10%9,00%11,2%
Assets1 62 94030 48061 01543 29550 33854 992
Book Value Per Share2 11,89,8410,110,010,913,0
Cash Flow per Share2 2,822,072,283,575,106,60
Capex1 1 3261 0439791 1471 2331 351
Capex / Sales 5,90%4,72%4,01%4,30%4,07%3,96%
Last update 02/02/201802/14/201902/14/202010/19/202010/19/202010/19/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (GBP)
105 994 170 293
Capitalization (USD)
137 968 331 003
Net sales (USD)
24 384 000 000
Number of employees
70 600
Sales / Employee (USD)
345 382
Free-Float
95,7%
Free-Float capitalization (GBP)
101 488 528 113
Free-Float capitalization (USD)
132 103 518 533
Avg. Exchange 20 sessions (USD)
10 720 471 941
Average Daily Capital Traded
10,11%
EPS & Dividend